Literature DB >> 19145702

The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts.

M J Weiss1, D A Guenther, J D Mezrich, H Sahara, C Y Ng, A J Meltzer, J K Sayre, M E Cochrane, A C Pujara, S L Houser, D H Sachs, B R Rosengard, J S Allan, G Benichou, J C Madsen.   

Abstract

We studied the effects of indirect allorecognition on the induction and maintenance phases of tolerance in miniature swine cotransplanted with heart and kidney allografts. MHC class I-mismatched heart and kidney grafts were cotransplanted in recipients receiving CyA for 12 days. Recipients were unimmunized or immunized with a set of donor-derived or control third-party MHC class I peptides either 21 days prior to transplantation or over 100 days after transplantation. T-cell proliferation, delayed type hypersensitivity reaction (DTH) and antibody production were assessed. All animals injected with donor MHC class I peptides developed potent indirect alloresponses specific to the immunizing peptides. While untreated recipients developed stable tolerance, all animals preimmunized with donor allopeptides rejected kidney-heart transplants acutely. In contrast, when peptide immunization was delayed until over 100 days after kidney-heart transplantation, no effects were observed on graft function or in vitro measures of alloimmunity. Donor peptide immunization prevented tolerance when administered to recipients pre transplantation but did not abrogate tolerance when administered to long-term survivors post transplantation. This suggests that the presence of T cells activated via indirect allorecognition represent a barrier to the induction but not the maintenance of tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19145702      PMCID: PMC3252388          DOI: 10.1111/j.1600-6143.2008.02494.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  50 in total

1.  Anti-vimentin antibodies are an independent predictor of transplant-associated coronary artery disease following cardiac transplantation.

Authors:  M L Rose
Journal:  Ital Heart J       Date:  2001-09

2.  Linked suppression of skin graft rejection can operate through indirect recognition.

Authors:  M P Wise; F Bemelman; S P Cobbold; H Waldmann
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

Review 3.  Tolerance and chronic rejection.

Authors:  M H Sayegh; C B Carpenter
Journal:  Kidney Int Suppl       Date:  1997-03       Impact factor: 10.545

4.  Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy.

Authors:  R S Lee; K Yamada; S L Houser; K L Womer; M E Maloney; H S Rose; M H Sayegh; J C Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 5.  The contribution of peptides to T cell allorecognition and allograft rejection.

Authors:  G Benichou; E V Fedoseyeva
Journal:  Int Rev Immunol       Date:  1996       Impact factor: 5.311

6.  Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.

Authors:  J Narula; L E Bennett; T DiSalvo; J D Hosenpud; M J Semigran; G W Dec
Journal:  Transplantation       Date:  1997-03-27       Impact factor: 4.939

7.  Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine.

Authors:  L R Pennington; J K Lunney; D H Sachs
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

8.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection.

Authors:  C P Larsen; P J Morris; J M Austyn
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

9.  Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.

Authors:  R I Lechler; J R Batchelor
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.

Authors:  G Benichou; P A Takizawa; C A Olson; M McMillan; E E Sercarz
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  5 in total

1.  Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis.

Authors:  Cavit D Kant; Yoshinobu Akiyama; Katsunori Tanaka; Susan Shea; Sarah E Connolly; Sharon Germana; Henry J Winn; Christian LeGuern; Georges Tocco; Gilles Benichou
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

Review 2.  State of the Art: Role of the Dendritic Cell in Induction of Allograft Tolerance.

Authors:  Sarah J Rosen; Paul E Harris; Mark A Hardy
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

3.  Tolerogenicity of donor major histocompatibility complex-matched skin grafts in previously tolerant Massachusetts general hospital miniature swine.

Authors:  Joshua Weiner; Joseph Scalea; Yoshinori Ishikawa; Masayoshi Okumi; Adam Griesemer; Atsushi Hirakata; Justin Etter; Bradford Gillon; Shannon Moran; Akira Shimizu; Kazuhiko Yamada; David H Sachs
Journal:  Transplantation       Date:  2012-12-27       Impact factor: 4.939

Review 4.  Maintaining T cell tolerance of alloantigens: Lessons from animal studies.

Authors:  Kortney A Robinson; William Orent; Joren C Madsen; Gilles Benichou
Journal:  Am J Transplant       Date:  2018-08       Impact factor: 8.086

5.  Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.

Authors:  Pervinder Sagoo; Giovanna Lombardi; Robert I Lechler
Journal:  Front Immunol       Date:  2012-07-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.